The invention belongs to the compositions field of antiviral drugs relate to the atomized inhalation of interferon-ALPHA and terbutaline sulphate.Described atomized inhalation contains the pharmaceutically acceptable auxiliaries of interferon-ALPHA terbutaline sulphate and the Sq for the treatment of effective dose; The interferon-ALPHA that contains 2.5-30 μ g in preferred single-dose dosage the terbutaline sulphate of 0.5-2mg and the pharmaceutically acceptable auxiliaries of Sq; More preferably contain the interferon-ALPHA of 10-20 μ g in single-dose dosage the terbutaline sulphate of 1-1.5mg and the pharmaceutically acceptable auxiliaries of Sq.With the atomized inhalation treatment viral pneumonia of interferon-ALPHA of the present invention and terbutaline sulphate can use more separately the treatment of interferon-ALPHA or terbutaline sulphate obviously to improve curative effect.

暂无附图